Effects of tobramycin solution for inhalation on global ratings of quality of life in patients with cystic fibrosis and Pseudomonas aeruginosa infection

Pediatric Pulmonology

Volumn 33, Issue 4, 2002, Pages 269-276

  Quittner, Alexandra L ^a   Buu, Anne ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Cystic fibrosis; Pseudomonas aeruginosa; Pulmonary function; Quality of life; Tobramycin solution for inhalation

Indexed keywords

PLACEBO; TOBRAMYCIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE SEVERITY; DRUG EFFECT; FEMALE; FORCED EXPIRATORY VOLUME; GRAM NEGATIVE INFECTION; HUMAN; INFECTION CONTROL; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NEBULIZER; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; VALIDATION PROCESS;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; CYSTIC FIBROSIS; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LOGISTIC MODELS; MALE; NEBULIZERS AND VAPORIZERS; ODDS RATIO; OUTCOME ASSESSMENT (HEALTH CARE); PSEUDOMONAS INFECTIONS; QUALITY INDICATORS, HEALTH CARE; RETROSPECTIVE STUDIES; TOBRAMYCIN;

EID: 0036204597     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.10074     Document Type: Article

References (19)

1. The changing epidemiology of cystic fibrosis
2. International comparison of median age at death from cystic fibrosis
3. Measurement of quality of life in cystic fibrosis
4. Treatment of cystic fibrosis in the adult
5. Cystic fibrosis: Current survival and population estimates to the year 2000
6. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis
7. Self-rated health and mortality: A review of twenty-seven community studies
8. Measures of association for ordinal variables
9. Changes in the normal maximal expiratory flow-volume curve with growth and aging
10. Introduction
11. Quality of life in cystic fibrosis
12. Quality of life studies: Definitions and conceptual issues
13. The quality of well-being scale applications in AIDS, cystic fibrosis, and arthritis
14. The quality of well-being in cystic fibrosis
15. Quality of life as a treatment outcome in patients with cystic fibrosis
16. Quality of well-being before and after antibiotic treatment of pulmonary exacerbation in patients with cystic fibrosis
17. Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis
18. Translation and linguistic validation of a disease-specific quality of life measure for cystic fibrosis